Douglas Matthew Brown - Apr 1, 2022 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Chief Strategy Officer
Signature
/s/ Halley E. Gilbert, Attorney-in-Fact
Stock symbol
NEO
Transactions as of
Apr 1, 2022
Transactions value $
$0
Form type
4
Date filed
4/4/2022, 07:07 PM
Previous filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Award $0 +82.3K +107.76% $0.00 159K Apr 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEO Stock Option (Right to Buy) 45K Apr 1, 2022 Common Stock 45K $28.33 Direct F2
holding NEO Stock Option (Right to Buy) 26.4K Apr 1, 2022 Common Stock 26.4K $53.17 Direct F3
holding NEO Stock Option (Right to Buy) 85.5K Apr 1, 2022 Common Stock 85.5K $21.41 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 1, 2022, Mr. Brown was granted 82,305 restricted stock awards. These awards vest on the first anniversary date of the grant date.
F2 On March 2, 2020, Mr. Brown was granted 45,017 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F3 On March 2, 2021, Mr. Brown was granted 26,378 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F4 On March 1, 2022, Mr. Brown was granted 85,519 stock options. These options vest ratably over the first four anniversary dates of the grant date.